Low-affinity nerve growth factor receptor (P75 NGFR) as a marker of perineural invasion in malignant melanomas

Journal of Cutaneous Pathology

Volumn 37, Issue 3, 2010, Pages 336-343

  Chan, Maren M ^a   Tahan, Steven R ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR RECEPTOR; TUMOR MARKER;

ARTICLE; BASAL CELL CARCINOMA; CANCER INVASION; HUMAN; IMMUNOHISTOCHEMISTRY; INNERVATION; MELANOMA; METABOLISM; PATHOLOGY; SKIN; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; NEOPLASM INVASIVENESS; RECEPTOR, NERVE GROWTH FACTOR; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 75749086436     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2009.01349.x     Document Type: Article

References (32)

1. Feasel AM, Brown TJ, Bogle MA, Tschen JA, Nelson BR. Perineural invasion of cutaneous malignancies. Dermatol Surg 2001 27 : 531.
2. Catalano PJ, Sen C, Biller HF. Cranial neuropathy secondary to perineural spread of cutaneous malignancies. Am J Otol 1995 16 : 772.
3. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skDermatol Surg 2002 28 : 268.
4. Terashi H, Kurata S, Tadokoro T, et al. Perineural and neural involvement in skin cancers. Dermatol Surg 1997 23 : 259.
5. Goepfert H, Dichtel WJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984 148 : 542.
6. Quinn MJ, Crotty KA, Thompson JF, Coates AS, O'Brien CJ, McCarthy WH. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998 83 : 1128.
7. Walling HW, Fosko SW, Geraminejad PA, Whitaker DC, Arpey CJ. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev 2004 23 : 389.
8. Matorin PA, Wagner RF Jr. Mohs micrographic surgery: technical difficulties posed by perineural invasion. Int J Dermatol 1992 31 : 83.
9. McCarthy SW, Scolyer RA, Palmer AA. Desmoplastic melanoma: a diagnostic trap for the unwary. Pathology 2004 36 : 445.
10. DiMaio SM, Mackay B, Smith JL Jr., Dickersin GR. Neurosarcomatous transformation in malignant melanoma: an ultrastructural study. Cancer 1982 50 : 2345.
11. Carlson JA, Dickersin GR, Sober AJ, Barnhill RL. Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases. Cancer 1995 75 : 478.
12. Warner TF, Hafez GR, Finch RE, Brandenberg JH. Schwann cell features in neurotropic melanoma. J Cutan Pathol 1981 8 : 177.
13. Iwamoto S, Odland PB, Piepkorn M, Bothwell M. Evidence that the p75 neurotrophin receptor mediates perineural spread of desmoplastic melanoma. J Am Acad Dermatol 1996 35 : 725.
14. Kanik AB, Yaar M, Bhawan J. p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma. J Cutan Pathol 1996 23 : 205.
15. Barker PA. p75NTR is positively promiscuous: Novel partners and new insights. Neuron 2004 42 : 529.
16. Schor NF. The p75 neurotrophin receptor in human development and disease. Prog Neurobiol 2005 77 : 201.
17. Fanburg-Smith JC, Miettinen M. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues. Hum Pathol 2001 32 : 976.
18. Innominato PF, Libbrecht L, van den Oord JJ. Expression of neurotrophins and their receptors in pigment cell lesions of the skJ Pathol 2001 194 : 95.
19. Chen-Tsai CP, Colome-Grimmer M, Wagner RF Jr. Correlations among neural cell adhesion molecule, nerve growth factor, and its receptors, TrkA, TrkB, TrkC, and p75, in perineural invasion by basal cell and cutaneous squamous cell carcinomas. Dermatol Surg 2004 30 : 1009.
20. Lewis Kelso R, Colome-Grimmer MI, Uchida T, Wang HQ, Wagner RF Jr. p75(NGFR) immunostaining for the detection of perineural invasion by cutaneous squamous cell carcinoma. Dermatol Surg 2006 32 : 177.
21. Jih DM, Lyle S, Elenitsas R, Elder DE, Cotsarelis G. Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells. J Cutan Pathol 1999 26 : 113.
22. Kruger K, Blume-Peytavi U, Orfanos CE. Basal cell carcinoma possibly originates from the outer root sheath and/or the bulge region of the vellus hair follicle. Arch Dermatol Res 1999 291 : 253.
23. LeBoit PE. Puzzling follicular germinative proliferations. Am J Dermatopathol 2000 22 : 87.
24. Botchkarev VA, Botchkareva NV, Peters EM, Paus R. Epithelial growth control by neurotrophins: leads and lessons from the hair follicle. Prog Brain Res 2004 146 : 493.
25. Reed JA, Finnerty B, Albino AP. Divergent cellular differentiation pathways during the invasive stage of cutaneous malignant melanoma progression. Am J Pathol 1999 155 : 549.
26. Zorick TS, Lemke G. Schwann cell differentiation. Curr Opin Cell Biol 1996 8 : 870.
27. Mirsky R, Jessen KR. Schwann cell development, differentiation and myelination. Curr Opin Neurobiol 1996 6 : 89.
28. Teng KK, Hempstead BL. Neurotrophins and their receptors: signaling trios in complex biological systems. Cell Mol Life Sci 2004 61 : 35.
29. Theonen J, Barde YA. Physiology of nerve growth factor. Physiol Rev 1980 1284.
30. Anton ES, Weskamp G, Reichardt LF, Matthew WD. Nerve growth factor and its low-affinity receptor promote Schwann cell migration. Proc Natl Acad Sci U S A 1994 91 : 2795.
31. Herrmann JL, Menter DG, Hamada J, Marchetti D, Nakajima M, Nicolson GL. Mediation of NGF-stimulated extracellular matrix invasion by the human melanoma low-affinity p75 neurotrophin receptor: melanoma p75 functions independently of trkA. Mol Biol Cell 1993 4 : 1205.
32. Walch ET, Albino AP, Marchetti D. Correlation of overexpression of the low-affinity p75 neurotrophin receptor with augmented invasion and heparanase production in human malignant melanoma cells. Int J Cancer 1999 82 : 112.